Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Brimonidine is an α2 agonist medication used to treat open-angle glaucoma, ocular hypertension, and rosacea. In rosacea it improves the redness. It is used as eye drops or applied to the skin. It is also available in the fixed-dose combination medication brimonidine/timolol along with timolol maleate.
Applications, Overview & Medical uses
Explore the main themes, entities and connections around Brimonidine. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
medication used redness applied skin side effects include rosacea may eye blood use α2 ocular names agonist glaucoma available common
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Brimonidine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Brimonidine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Brimonidine | ATC code | D11AX21 (WHO) S01EA05 (WHO), S01EA55 (WHO), S01GA07 (WHO) | 1.00 | infobox |
| Brimonidine | CAS Number | 59803-98-4 Y | 1.00 | infobox |
| Brimonidine | ChEBI | CHEBI:3175 Y | 1.00 | infobox |
| Brimonidine | ChEMBL | ChEMBL844 Y | 1.00 | infobox |
| Brimonidine | ChemSpider | 2341 Y | 1.00 | infobox |
| Brimonidine | CompTox Dashboard (EPA) | DTXSID3045221 | 1.00 | infobox |
| Brimonidine | DrugBank | DB00484 Y | 1.00 | infobox |
| Brimonidine | ECHA InfoCard | 100.149.042 | 1.00 | infobox |
| Brimonidine | Elimination half-life | 3 hours (ocular), 12 hours (topical) | 1.00 | infobox |
| Brimonidine | Formula | C11H10BrN5 | 1.00 | infobox |
| Brimonidine | IUPHAR/BPS | 520 | 1.00 | infobox |
| Brimonidine | KEGG | D07540 Y | 1.00 | infobox |
| Brimonidine | Legal status | AU: S4 (Prescription only) / Schedule 2 | 1.00 | infobox |
| Brimonidine | Legal status | US: ℞-only / OTC | 1.00 | infobox |
| Brimonidine | License data | US DailyMed: Brimonidine | 1.00 | infobox |
| Brimonidine | MedlinePlus | a601232 | 1.00 | infobox |
| Brimonidine | Melting point | 252 °C (486 °F) | 1.00 | infobox |
| Brimonidine | Metabolism | Primarily liver | 1.00 | infobox |
| Brimonidine | Molar mass | 292.140 g·mol−1 | 1.00 | infobox |
| Brimonidine | Pregnancy category | AU: B3 | 1.00 | infobox |
| Brimonidine | Pronunciation | /brɪˈmoʊnɪdiːn/ bri-MOH-nid-een | 1.00 | infobox |
| Brimonidine | PubChem CID | 2435 | 1.00 | infobox |
| Brimonidine | Routes of administration | Topical | 1.00 | infobox |
| Brimonidine | Trade names | Alphagan, Mirvaso, Lumify, others | 1.00 | infobox |
| Brimonidine | UNII | E6GNX3HHTE | 1.00 | infobox |
| Brimonidine | is a | α2 agonist medication used to treat open-angle glaucoma | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.